R

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Associate Director - Health Economics & Outcomes Research, Solid Tumors

Biology & BiotechConfirmed live in the last 24 hours
Full-timeSleepy Hollow, NY, USA$176.1k - $287.3k /yr

About the Job

Requirements

  • An advanced degree (Ph.D., MS, MD, PharmD, or B.Pharm with a master's degree) in an HEOR-related field, plus 4 or more years of HEOR experience with a Ph.D. or 6 or more years with an MS.
  • Strong technical expertise in the design and conduct of HEOR studies and models.
  • A solid understanding of regulatory considerations, including FDA and EMA, and health technology assessment considerations.
  • Experience designing and implementing patient experience data in clinical trials, including instrument selection, data analysis, and reporting.

Responsibilities

  • Develop and implement HEOR strategies and programs throughout the product lifecycle to inform and support clinical development and regulatory needs during the early pipeline phase and to ensure optimal market access.
  • Collaborate with business partners to develop and support compelling product value propositions aimed at optimizing patient access.
  • Identify HEOR evidence requirements and gaps, and design, conduct, and deliver studies and tools to support relative value demonstration and product differentiation.
  • Leverage real-world data (RWD) analytic tools and collaborate with HEOR RWDnA and Epidemiology teams to generate insights that inform development programs and key business questions.
  • Co-lead regulatory-grade real-world evidence (RWE) studies and provide education on emerging opportunities for employing RWE across the solid tumor portfolio.
  • Collaborate on epidemiology and pharmacoepidemiology analyses and studies, including their conduct and communication.
  • Provide input into the selection of patient populations, comparators, and endpoints within clinical trials to demonstrate robust incremental value over the standard of care and facilitate optimal patient access.
  • Develop and implement Clinical Outcomes Assessment (COA) measurement strategies and plans to support product labeling, patient access, and product differentiation.
  • Develop and validate COA endpoints for integration in clinical studies, and produce COA evidence dossiers for regulatory submissions.
  • Evaluate relevant payer and health technology assessment decisions, collect feedback in advisory meetings, and apply key takeaways.
  • Maintain current awareness of regulatory and payer/health technology assessment considerations that may affect the planning and implementation of HEOR programs.
  • Report, publish, and disseminate HEOR data and study results in compliance with company, industry, and regulatory requirements.

Desired Qualifications

  • At least 3 years of life sciences company or healthcare consulting experience.
  • Experience with oncology.

About the Company

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Regeneron Pharmaceuticals develops and commercializes medicines for serious diseases, with a focus on cancer, eye diseases, allergic and inflammatory diseases, and infectious diseases. Its products come from using proprietary research capabilities and technologies to discover and develop therapies, often in collaboration with academic, research, and industry partners. Revenue comes from selling approved medicines and from licensing its technologies and entering co-development and co-commercialization partnerships. The company works with healthcare providers and regulators to ensure treatment delivery and safety. Its goal is to improve patient outcomes by bringing life-transforming medicines to market through rigorous R&D and strategic collaborations, maintaining leadership in biopharmaceutical innovation.

Company size
10,001+
Company stage
IPO
Headquarters
Town of Mount Pleasant, New York
Founded
1988

Recently Posted Jobs

Explore more opportunities at Regeneron Pharmaceuticals

See more jobs